Tae Hong Park (TaeHong Park, Taehong Park)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Ankylosing Spondylitis

Early Breast Cancer

Chronic Lymphocytic Leukemia

Top Venues

Expert opinion on biological therapy

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Min-Ho Park, Jae Hong Seo, Jung Ho Park, Min-Ki Seong, Keon Uk Park, Min Kyoon Kim, Myung Chul Chang, Su Jin Koh, Moon Hee Lee, Seung Taek Lim, Young-Bum Yoo, So Yeon Oh, Sung Hyun Kim, Keum Young Ahn, Tae Hong Park, Hana Ju, Eric Hyungseok Baek, Sinhye Kim, Nahyun Kim, Eunkyung Lee, Tae Hyun Kim
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study. Expert opinion on biological therapy 24 (4) (2024)
Min-Ho Park, Jae Hong Seo, Jung Ho Park, Min-Ki Seong, Keon Uk Park, Min Kyoon Kim, Myung Chul Chang, Su Jin Koh, Moon Hee Lee, Seung Taek Lim, Young-Bum Yoo, So Yeon Oh, Sung Hyun Kim, Keum Young Ahn, Tae Hong Park, Hana Ju, Eric Hyungseok Baek, Sinhye Kim, Nahyun Kim, Eunkyung Lee, Tae Hyun Kim
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study. Expert opinion on biological therapy 24 (4) (2024)
Min-Ho Park, Jae Hong Seo, Jung Ho Park, Min-Ki Seong, Keon Uk Park, Min Kyoon Kim, Myung Chul Chang, Su Jin Koh, Moon Hee Lee, Seung Taek Lim, Young-Bum Yoo, So Yeon Oh, Sung Hyun Kim, Keum Young Ahn, Tae Hong Park, Hana Ju, Eric Hyungseok Baek, Sinhye Kim, Nahyun Kim, Eunkyung Lee, Tae Hyun Kim
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study. Expert opinion on biological therapy 24 (4) (2024)
Min-Ho Park, Jae Hong Seo, Jung Ho Park, Min-Ki Seong, Keon Uk Park, Min Kyoon Kim, Myung Chul Chang, Su Jin Koh, Moon Hee Lee, Seung Taek Lim, Young-Bum Yoo, So Yeon Oh, Sung Hyun Kim, Keum Young Ahn, Tae Hong Park, Hana Ju, Eric Hyungseok Baek, Sinhye Kim, Nahyun Kim, Eunkyung Lee, Tae Hyun Kim
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study. Expert opinion on biological therapy (2024)
Jae-Cheol Jo, Young-Woo Jeon, Da Jung Kim, Deok-Hwan Yang, Won Sik Lee, Yoon Seok Choi, Jun Ho Yi, Dok Hyun Yoon, Jee Hyun Kong, Jung-Yoon Choe, SungHyun Kim, Keum Young Ahn, Tae Hong Park, Hana Ju, Soonbum Kwon, Seok-Goo Cho
A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea. Expert opinion on biological therapy (2023)
Justin Stebbing, Yauheni Baranau, Valery Baryash, Vladimir Moiseyenko, Dmytro Boliukh, Nicoleta Antone, Alexey Manikhas, Anatolii Chornobai, Tae Hong Park, Eric Hyungseok Baek, Jaeyong Lee, Jiin Choi, Nahyun Kim, Keum Young Ahn, Sang Joon Lee, Sunghyun Kim
Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
Sang-Heon Cho, Seunghoon Han, Jong Lyul Ghim, Moon Suk Nam, Sunyoung Yu, Tae Hong Park, Sinhye Kim, Jihun Bae, Jae-Gook Shin
A Randomized, Double-Blind Trial Comparing the Pharmacokinetics of CT-P16, a Candidate Bevacizumab Biosimilar, with its Reference Product in Healthy Adult Males. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 33 (2) (2019)